Fang-An Chen

553 total citations
15 papers, 463 citations indexed

About

Fang-An Chen is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Fang-An Chen has authored 15 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 6 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Fang-An Chen's work include Immunotherapy and Immune Responses (9 papers), Immune Cell Function and Interaction (6 papers) and RNA Interference and Gene Delivery (3 papers). Fang-An Chen is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), Immune Cell Function and Interaction (6 papers) and RNA Interference and Gene Delivery (3 papers). Fang-An Chen collaborates with scholars based in United States, Japan and Canada. Fang-An Chen's co-authors include Richard B. Bankert, Nejat K. Egilmez, Hiroshi Takita, Yoshimi Iwanuma, Michael S. Sabel, Yoshihiro Kawaguchi, Thomas F. Conway, M Sugano, Jennifer Harding and S K Huang and has published in prestigious journals such as International Journal of Cancer, Journal of Immunological Methods and Cancer Immunology Immunotherapy.

In The Last Decade

Fang-An Chen

14 papers receiving 450 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fang-An Chen United States 13 197 181 156 86 85 15 463
Tetsunari Kihira Japan 12 95 0.5× 209 1.2× 63 0.4× 72 0.8× 72 0.8× 16 393
Garrett C. Booth United States 9 136 0.7× 235 1.3× 89 0.6× 71 0.8× 51 0.6× 10 458
Gregory J. Duigou United States 11 142 0.7× 279 1.5× 162 1.0× 73 0.8× 26 0.3× 22 528
Wanhua Yang China 12 204 1.0× 201 1.1× 173 1.1× 86 1.0× 26 0.3× 20 532
Leon Carayannopoulos United States 8 219 1.1× 357 2.0× 101 0.6× 190 2.2× 36 0.4× 10 635
Xiaoli Hui China 10 81 0.4× 217 1.2× 187 1.2× 106 1.2× 47 0.6× 16 479
E. Pflüger Germany 7 190 1.0× 144 0.8× 117 0.8× 73 0.8× 17 0.2× 7 442
Peyman Hosseinchi United States 8 430 2.2× 215 1.2× 402 2.6× 82 1.0× 58 0.7× 9 717
Kausar N. Samli United States 8 59 0.3× 304 1.7× 109 0.7× 213 2.5× 41 0.5× 9 465
Joshua W. Collins United States 7 112 0.6× 337 1.9× 127 0.8× 62 0.7× 24 0.3× 12 571

Countries citing papers authored by Fang-An Chen

Since Specialization
Citations

This map shows the geographic impact of Fang-An Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fang-An Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fang-An Chen more than expected).

Fields of papers citing papers by Fang-An Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fang-An Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fang-An Chen. The network helps show where Fang-An Chen may publish in the future.

Co-authorship network of co-authors of Fang-An Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Fang-An Chen. A scholar is included among the top collaborators of Fang-An Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fang-An Chen. Fang-An Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Sabel, Michael S., Stephen D. Hess, Nejat K. Egilmez, et al.. (2005). CTLA-4 blockade augments human T lymphocyte-mediated suppression of lung tumor xenografts in SCID mice. Cancer Immunology Immunotherapy. 54(10). 944–952. 15 indexed citations
3.
Egilmez, Nejat K., Stephen D. Hess, Fang-An Chen, et al.. (2002). Human CD4+ effector T cells mediate indirect interleukin-12- and interferon-gamma-dependent suppression of autologous HLA-negative lung tumor xenografts in severe combined immunodeficient mice.. PubMed. 62(9). 2611–7. 24 indexed citations
4.
Sugiyama, Yasuyuki, Motohisa Kato, Fang-An Chen, et al.. (2001). Human Inflammatory Cells Within the Tumor Microenvironment of Lung Tumor Xenografts Mediate Tumor Growth Suppression in Situ that Depends on and Is Augmented by Interleukin-12. Journal of Immunotherapy. 24(1). 37–45. 21 indexed citations
5.
6.
Sabel, Michael S., Thomas F. Conway, Fang-An Chen, & Richard B. Bankert. (2000). Monoclonal Antibodies Directed Against the T-Cell Activation Molecule CD137 (Interleukin-A or 4-1BB) Block Human Lymphocyte-Mediated Suppression of Tumor Xenografts in Severe Combined Immunodeficient Mice. Journal of Immunotherapy. 23(3). 362–368. 11 indexed citations
7.
Conway, Thomas F., Michael S. Sabel, Masahiko Sugano, et al.. (2000). Growth of human tumor xenografts in SCID mice quantified using an immunoassay for tumor marker protein in serum. Journal of Immunological Methods. 233(1-2). 57–65. 20 indexed citations
8.
Sabel, Michael S., et al.. (2000). CD40 expression on human lung cancer correlates with metastatic spread. Cancer Immunology Immunotherapy. 49(2). 101–108. 50 indexed citations
9.
Sugano, M, Nejat K. Egilmez, Soichiro Yokota, et al.. (2000). Antibody targeting of doxorubicin-loaded liposomes suppresses the growth and metastatic spread of established human lung tumor xenografts in severe combined immunodeficient mice.. PubMed. 60(24). 6942–9. 79 indexed citations
10.
Egilmez, Nejat K., Yong S. Jong, Yoshimi Iwanuma, et al.. (1998). Cytokine immunotherapy of cancer with controlled release biodegradable microspheres in a human tumor xenograft/SCID mouse model. Cancer Immunology Immunotherapy. 46(1). 21–24. 56 indexed citations
11.
Iwanuma, Yoshimi, Fang-An Chen, Nejat K. Egilmez, Hiroshi Takita, & Richard B. Bankert. (1997). Antitumor immune response of human peripheral blood lymphocytes coengrafted with tumor into severe combined immunodeficient mice.. PubMed. 57(14). 2937–42. 43 indexed citations
12.
Sakakibara, Takashi, Fang-An Chen, Hisashi Kida, et al.. (1996). Doxorubicin encapsulated in sterically stabilized liposomes is superior to free drug or drug-containing conventional liposomes at suppressing growth and metastases of human lung tumor xenografts.. PubMed. 56(16). 3743–6. 52 indexed citations
13.
Chen, Fang-An, et al.. (1994). Clones of Tumor Cells Derived from a Single Primary Human Lung Tumor Reveal Different Patterns of β1Integrin Expression. Cell adhesion and communications/Cell adhesion and communication/Cell adhesion & communication. 2(4). 345–357. 16 indexed citations
14.
Sugiyama, Yasuyuki, Fang-An Chen, Hiroshi Takita, & Richard B. Bankert. (1988). Selective growth inhibition of human lung cancer cell lines bearing a surface glycoprotein gp160 by 125I-labeled anti-gp160 monoclonal antibody.. PubMed. 48(10). 2768–73. 17 indexed citations
15.
Zylstra, Samuel, Fang-An Chen, Swapan K. Ghosh, et al.. (1986). Membrane-associated glycoprotein (gp 160) identified on human lung tumors by a monoclonal antibody.. PubMed. 46(12 Pt 1). 6446–51. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tetsunari Kihira Breakdown of academic impact, for papers by Garrett C. Booth Breakdown of academic impact, for papers by Gregory J. Duigou Breakdown of academic impact, for papers by Wanhua Yang Breakdown of academic impact, for papers by Leon Carayannopoulos Breakdown of academic impact, for papers by Xiaoli Hui Breakdown of academic impact, for papers by E. Pflüger Breakdown of academic impact, for papers by Peyman Hosseinchi Breakdown of academic impact, for papers by Kausar N. Samli Breakdown of academic impact, for papers by Joshua W. Collins
Rankless by CCL
2026